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Abstract: The goal of this study was to develop a clinically relevant non-human primate (baboon) stroke model and 
multi-parametric MRI protocols on a clinical scanner with long-term goals to better model human stroke and facilitate 
clinical translations of novel therapeutic strategies. Baboons were chosen because of their relatively large brain volume 
and that they are evolutionarily close to humans. Middle cerebral artery occlusion (MCAO) was induced using a 
minimally invasive endovascular approach to guide an inflatable balloon catheter into the MCA and followed by   
permanently or transiently inflate the balloon. Using multimodal MRI, including perfusion and diffusion imaging, the 
spatiotemporal dynamic evolution of the ischemic lesions in permanent and transient occlusion experiments in baboons 
were investigated. Perfusion-diffusion mismatch, which approximates the ischemic penumbra, was detected. In the 
permanent MCAO group (n = 2), the mean infarct volume was 29 ml (17% of total brain volume) whereas in the transient 
MCAO group (n = 2, 60 or 90 min of occlusion), the mean infarct volume was 15 ml (9% of total brain volume). 
Substantial perfusion-diffusion mismatch tissue (~50%) was salvaged by reperfusion compared to permanent MCAO. 
This baboon stroke model has the potential to become a translational platform to better design clinical studies, guide 
clinical diagnosis and improve treatment time windows in patients.  
Keywords: Penumbra, cerebral ischemia, middle cerebral artery occlusion, nonhuman primate, perfusion, diffusion, magnetic 
resonance imaging. 
INTRODUCTION  
  Ischemic stroke is a major cause of death and a leading 
cause of long-term disability worldwide, constituting a major 
societal burden. One of the major goals of stroke research is 
to develop clinically relevant stroke models and find ways to 
identify viable tissue in a timely manner using noninvasive 
imaging methods. The ischemic penumbra, tissue at risk 
surrounding the initial ischemic core, is potentially 
salvageable if treated in a timely manner [1]. Diffusion-
weighted imaging (DWI), in which contrast is based on early 
changes in the apparent diffusion coefficient (ADC) of 
water, is a powerful tool for early detection of ischemic brain 
injury [2]. Ischemic lesions are apparent as regions of 
hyperintensity in diffusion weighted images and 
hypointensity in apparent diffusion coefficient maps. A 
stroke lesion is characterized by regions of decreased ADC, 
and the signal intensity within this region may be quite 
inhomogeneous. Often there is an infarcted lesion core 
(ADC decrease of 30-50% from baseline) and a 
hypoperfused lesion periphery (mild to moderate decrease in 
ADC) [3].  
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  Perfusion-weighted imaging (PWI) highlights brain 
tissue regions with abnormal or deficient cerebral blood flow 
(CBF). Tissue surrounding by regions of severely decreased 
diffusion abnormality that have a perfusion deficit, but no 
diffusion abnormality exhibit a phenomenon referred to as 
the “perfusion-diffusion mismatch”, which has been shown 
to approximate the ischemic penumbra [4-6].  
  Experimental stroke models are instrumental in the 
development of imaging tools to identify viable tissue, to 
study stroke pathophysiology, and to test novel interventions 
under controlled experimental conditions. The availability 
and ease of manipulation of rodent models have greatly 
advanced our understanding of cerebral ischemia. While 
numerous treatments have been shown to be effective in 
rodent stroke models, none, with the exception of 
recombinant tissue plasimogen activator (rtPA), has proven 
to be effective clinically. A possible explanation is that 
rodent stroke models may not sufficiently reflect the 
complexity of human neurophysiology in stroke. The Stroke 
Therapy Academic Industry Roundtable (STAIR) has 
recommended that new stroke intervention strategies be 
tested on animals that are evolutionarily closer to humans, 
such as nonhuman primates (NHPs), before clinical trials [7]. 
NHP brains share more similar vascular anatomy and 
neurophysiological function to humans compared to other 
lower animal species, such as rodents. Thus, NHP stroke 
characteristics, in principle, should better model human 
stroke, providing an important preclinical test bed to 148    The Open Neuroimaging Journal, 2011, Volume 5  Wey et al. 
accelerate translation of novel intervention strategies to 
clinical practices. 
  NHPs have been used as stroke models [8-15] but studies 
in which MRI, beyond basic anatomical imaging, was 
employed are sparse. Changes in perfusion, diffusion and/or 
fractional anisotropy in marmosets [9, 16], macaque [15, 17, 
18] and baboon [19] stroke models have been reported. 
However, studies that show the perfusion-diffusion 
mismatch phenomenon in NHP stroke models have not been, 
to our knowledge, systematically investigated. 
  The goal of this study was to develop a baboon stroke 
model and multi-parametric MRI protocols on a clinical 
scanner with the long-term goals to better model human 
stroke and facilitate clinical translations of novel therapeutic 
strategies. Baboons were chosen because they have large 
brain volumes (i.e., more than twice that of macaques) with 
extensive cortical folding [20, 21] making them amenable to 
MRI studies. The large vessel size also facilitates 
endovascular approach to the MCA. A minimally invasive 
endovascular approach was utilized to induce stroke, which 
is well suited for MRI studies, in contrast to the more 
invasive transorbital or intracranial procedures [8]. With 
multimodal MRI, including perfusion and diffusing imaging, 
the spatiotemporal dynamic evolution of ischemic lesion in 
permanent and transient stroke in baboons were investigated.  
MATERIALS AND METHODOLOGY  
Stroke Model 
  Four normal female baboons (Papio hamadryas spp., 14-
19 kg, 16 ± 2 kg) were studied with approval from the 
Institutional Animal Care and Use Committee of the 
University of Texas Health Science Center at San Antonio. 
Anesthesia was induced with ketamine (10 mg/Kg i.m.) for 
intubation and catheterization for fluid supplementation. 
Animals were mechanically ventilated and anesthetized with 
1.5%-2.0% isoflurane in medical air during surgical 
cannulation of the femoral artery. End-tidal CO2 (ETCO2), 
O2 saturation, heart rate, and respiration rate were 
continuously monitored during surgery. 
  Permanent (n = 2) or transient (60- or 90-min, n = 2) 
middle cerebral artery occlusion (MCAO) was induced using 
minimally invasive endovascular techniques. Occlusion on 
the right or left MCA was determined randomly among 
different animals. Access to the right common femoral artery 
employed a micropuncture set and the Seldinger technique. 
A 5 Fr vascular sheath was inserted into the femoral artery 
over a 0.035” guide wire (Bentson, AngioDynamics, 
Latham, NY, USA). Selective catheterization of the internal 
carotid artery (ICA) was accomplished using a 5 Fr catheter 
(VER135, Cordis, Bridgewater, NJ, USA) over the glide 
wire. Selective anterior cerebral angiogram and road 
mapping (Siemens SIREMOBIL Compact L) were 
performed by injecting contrast media (Omnipaque, GE 
Healthcare, Buckinghamshire, UK) through the guiding 
catheter at the ICA. A smaller HyperGuide balloon catheter 
(3x10 mm, EV3, Irvine, CA, USA) was inserted over its 
0.010” glide wire, coaxially through the guiding catheter into 
the MCA. The balloon catheter was inflated to occlude the 
M2 segment of the MCA. Occlusion was confirmed with an 
anterior cerebral angiogram. The balloon catheter (which is 
not MRI compatible) was deflated and withdrawn after 60 or 
90 min of occlusion. After stroke surgery, all of the catheters 
were removed and the animal was transported to the MRI 
suite down the hall. Non-reperfusion was subsequently 
confirmed in two animals (permanent MCAO group, 60- or 
90-min occlusion before withdrawing the occluder) and 
successful reperfusion was confirmed in the other two 
animals (transient MCAO group) throughout the MRI 
studies using magnetic resonance angiography (MRA). 
  The animal preparations for MRI studies in baboons have 
been described previously [22, 23]. Briefly, the animal was 
positioned supine and secured in a custom-made, MRI 
compatible animal holder and stabilized with ear bars, a 
mouth bar and padding around the head before 
transportation. During MRI, isoflurane was lowered to 
0.8%~1.0% and added anesthetic support achieved with 
vecuronium (0.2 mg/kg bolus and 0.02 mg/kg as needed, 
i.v.). Rectal temperature was maintained within normal 
physiological ranges (37-38 °C) using a feedback-regulated 
circulating warm-air blanket. ETCO2, O2 saturation, heart 
rate, and respiration rate were continuously monitored with 
an MRI-compatible physiological monitor device (Precess, 
InVivo, Orlando, FL, USA) during imaging. Blood gases and 
blood glucose were typically sampled once or twice after 
during stroke surgery and during MRI. All physiological 
parameters were maintained within normal ranges.  
  MRI acquisition started 30-60 min after withdrawal of 
the balloon occluder. One block of MRI acquisitions was 
repeated every 30 min up to 8 hours (permanent MCAO) 
after occlusion or 3 hours (transient MCAO) after 
reperfusion. Follow-up MRIs on days 1, 3, 7, and 30 after 
stroke were acquired in the transient MCAO group. In the 
permanent MCAO group, animals were euthanized 8 hrs 
post-occlusion. Permanent MCAO was confirmed by MRA 
periodically during MRI, In the transient MCAO group, one 
animal (60 min transient MCAO) was euthanized 30 days 
after stroke, and the other animal (90 min MCAO) was 
euthanized about 24 hrs after stroke due to degrading clinical 
signs, probably because of stroke lesion compressing the 
brain stem. In the transient MCAO group, recannalization 
was confirmed by MRA periodically during MRI studies. 
MRI Acquisition 
  MRI studies were performed on a clinical 3T Siemens 
TIM-Trio (Siemens Medical Solutions, Erlangen, Germany) 
using a standard 12-channel human head coil as a receiver 
and the integrated circularly polarized body coil as the 
transmitter. A 30-min block of MRI acquisitions included 
anatomical (3D high-resolution T1-weighted images and T2-
weighted fluid-attenuated inversion recovery (FLAIR) 
images), perfusion (pseudo-continuous arterial spin labeling, 
pCASL), diffusion MRI, and MRA. Anatomical T1-
weighting images were acquired using the MPRAGE pulse 
sequence with TR/TE = 2100/3.1 ms, flip angle = 12°, TI = 
1100 ms, FOV = 16x19.2x19.2 cm
3, 1 mm isotropic spatial 
resolution and NEX=2. T2-weighted FLAIR images were 
acquired with TR/TE/TI = 4000/76/1800 ms, 1x1x2 mm
3 
spatial resolution. pCASL images were acquired using a 
single-shot gradient-echo EPI with TR/TE = 3500/16 ms, 
labeling duration = 2.1 sec, 12 contiguous slices with 4 mm 
slice thickness, matrix = 64  64, FOV = 12.8  12.8 cm MRI of Perfusion-Diffusion Mismatch in Non-Human Primate  The Open Neuroimaging Journal, 2011, Volume 5    149 
(2x2x4 mm
3 resolution), labeling offset = 60 mm, and post-
labeling delay = 700 ms as described previously [22]. 
Diffusion-weighted MRI was acquired using TR/TE = 
4700/89 ms, b-value = 0 s/mm
2 and 1100 s/mm
2, 30 
directions, spin-echo EPI read-out with 2 mm isotropic 
resolution.  
Data Analysis 
  Data were processed using custom codes written in 
MATLAB (The MathWorks Inc., Natick, MA, USA). 
Quantitative cerebral blood flow was calculated as described 
in Wey et al. [22]. Apparent diffusion coefficient maps were 
calculated as described by Meng et al. [24]. Final infarct 
(corrected for edema as described in [24]) was determined on 
T2-FLAIR images on each of their last time point before 
euthanasia. Lesion volumes were determined by three 
independent observers manually drawing region-of-interests 
(ROIs) based on perfusion (CBF maps) and diffusion (ADC 
maps) images at all time points. ROIs of the infarct, defined 
by the endpoint T2-FLAIR images, were used for plotting 
temporal progression of MRI parameters. 
RESULTS  
  The animal physiology was maintained within normal 
ranges before and after MCAO as well as after recovery of 
the transient MCAO group. Animals who underwent 
transient MCAO regained consciousness after anesthetics 
were discontinued and had the ability of self-feeding within 
1 hour after they were awaken. One animal in the transient 
MCAO (60 min occlusion) showed a minor sign of 
movement deficit of the affected arm while the other (90 min 
occlusion) showed hemiparesis of both the affected arm and 
leg. 
 Fig.  (1) shows the cerebral angiogram of the brain of one 
animal with a permanent occlusion. Angiograms clearly 
show the patent right ICA (Fig. 1a, dashed arrow) and 
cerebral vasculature in the MCA territory. The position of 
the balloon was between the two radiopaque markers in the 
subtracted image (Fig. 1b, arrow). MCA occlusion, after 
balloon inflation, was angiographically confirmed by the 
absence of x-ray contrast distally (Fig. 1c, circled region). 
  In the contralateral hemisphere, quantitative CBF and 
ADC remained unchanged across all time points (data not 
shown). Fig. (2) shows representative MRA, CBF, and ADC 
maps at 30 min post-reperfusion, and the T2-weighted 
FLAIR image of the brain at end-point from a transient 
MCAO animal (90 min MCAO). An apparent post-ischemic 
early hyper-perfusion, as compared with the normal 
hemisphere, was observed within the previously occluded 
brain territory in this animal, indicative of efficient 
recannalization. The hypointense region in the ADC map 
indicated the ischemic zone. At 24 hours, T2-weighted 
FLAIR images revealed the infarct territory.  
 Fig.  (3) shows lesion volumes from the permanent 
MCAO group.  Hypointense regions within the CBF and 
ADC maps 4.5 hrs after occlusion indicated the ischemic 
territories. The time courses of the lesion volume evolution 
(from one animal) indicated that the CBF-defined lesion 
remained relatively unchanged whereas the ADC-defined 
lesion volume, which was initially small, grew over time 
time to that of the CBF-defined volume. The anatomical 
difference between CBF and ADC abnormalities, i.e., the 
perfusion-diffusion mismatch, was substantial, diminished 
over time, and disappeared by 6 hours post-occlusion. The 
average final infarct volume was ~29 mL from two animals 
(~17% of total brain volume).  
 Fig.  (4) shows the lesion volumes from the transient 
MCAO group. Hypointense regions in the ADC maps 1 hr 
after reperfusion indicate the ischemic territories. Hyper- and 
hypo-perfusion, as compared with the normal hemisphere, 
were observed after reperfusion (Fig. 4a). The time course of 
the ADC-defined lesion volume (from one animal, 60 min 
MCAO) was markedly different from that of the permanent 
MCAO group. ADC-defined lesion volume decreased with 
time during the first few hours after reperfusion and peaked 
1 day after stroke, and was followed by a secondary decrease 
on days 3 and 7, likely due to ADC renormalization. The 
infarct volume was defined by the endpoint. The T2-
weighted FLAIR image volume was slightly larger than the 
ADC-defined lesion volume. The final infarct volume 
defined by T2-weighted FLAIR was ~4 mL in this 
representative animal (60 min MCAO), and ~26 mL in the 
other animal of the MCAO group (90 min MCAO, Fig. 2). 
The averaged final infarct volume, defined by T2-weighted 
Fig. (1). Cerebral x-ray angiography (fluoroscopy) with an anterior-posterior view during stroke procedures: (a) right hemisphere cerebral 
angiogram with contrast injected via the right carotid artery before occlusion, (b) subtracted digital radiography showing the position of the 
balloon (arrow), (c) right hemisphere cerebral angiogram with contrast injected in the right carotid artery after balloon occlusion of the 
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FLAIR, was ~15 mL from the two animals (~9% of total 
brain volume), indicating that reperfusion salvaged 
substantial mismatch tissue compared to permanent MCAO 
(29mL, ~17% of total brain volume). 
DISCUSSION 
  This study describes a minimally invasive endovascular 
surgical procedure to induce permanent and transient MCAO 
in a clinically relevant, large non-human primate (baboon) 
model and a multimodal MRI protocol to longitudinally 
characterize ischemic evolution. Perfusion-diffusion 
mismatch in the MR images, which approximated the 
ischemic penumbra, was detected. A substantial amount of 
the mismatched tissue was salvaged by early reperfusion 
compared to the permanent MCAO model.  
  In this baboon model, permanent MCAO, the perfusion-
diffusion (PWI-DWI) mismatch detected was similar to 
those reported in humans and rodents. The mismatch volume 
progressively decreased for up to 6 hours post-occlusion, in 
contrast to mismatch volumes in rodent models which lasted 
up to 3 hours post-occlusion [25]. In humans, PWI-DWI 
mismatch is often detected ~6-12 hours after stroke onset. 
 
Fig. (2). A representative set of MR images from a baboon which underwent 90-min transient MCAO on the right side, including (a) MRA 
after reperfusion, (b) cerebral blood flow (CBF) map, (c) apparent diffusion coefficient (ADC) map, and (d) end-point T2-weighted FLAIR 
at 24 hours post-occlusion. 
 
Fig. (3). Permanent MCAO: (a) cerebral blood flow (CBF, upper row) and apparent diffusion coefficient (ADC, lower row) maps of an 
animal which underwent permanent occlusion. (b) Temporal evolution of lesion volumes were defined by abnormal CBF and ADC. The 
difference between the two lines indicates the perfusion-diffusion mismatch. The grayscale bar indicates a CBF of 0 to 120 mL/100g/min and 
an ADC of 0 to 0.3 x 10
-3 mm
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The frequency of detection decreased with time [26]. The 
temporal topography of PWI-DWI mismatch in humans 
appeared more similar to that observed in baboons than that 
reported in rodents.  
  Early recannalization salvaged a substantial portion of 
tissue immediately after reperfusion when compared with 
those subjects with infarcts but without reperfusion. The 
ADC-defined lesion decreased a few hours after reperfusion 
but grew markedly after day 1, consistent with the reports in 
rodents [24] and humans [4-6]. Although the T2-weighted 
FLAIR infarct volume of the transient MCAO group peaked 
at day 7, it was markedly smaller than that of the permanent 
MCAO group, indicating that reperfusion salvaged a 
substantial amount of tissue which provides evidence 
supporting the concept of the mismatch in this stroke model. 
Comparing our results with the published results in rodents, 
infarct volume typically stopped evolving by 1 or 2 days 
after stroke [24]. This finding further corroborates the notion 
that ischemic evolution in human brains appears to be more 
similar to that seen in the NHP model than in rodent models.  
  Early post-ischemic hyperperfusion was detected in the 
transient MCAO group but not in the permanent MCAO 
group. This observation suggests that this NHP model could 
offer an opportunity to investigate hyperperfusion in stroke. 
Early post-ischemic hyperperfusion, a common phenomenon 
in human stroke patients [27, 29], and rodent stroke model 
[30] is an indicator of successful reperfusion. Controversy 
exists regarding whether early post-ischemic hyperperfusion 
is beneficial or harmful [27-29]. In the transient MCAO of 
this study,  regions on with early post-ischemic 
hyperperfusion eventually developed into infarct, suggesting 
possible reperfusion injury. Additional studies with this 
baboon stroke model might provide insights for developing 
interventions against reperfusion injury.  
  The major shortcomings of the current study are: 1) 
Reproducibility of the stroke model has not yet been fully 
established given the small sample sizes, 2) MRI during 
occlusion would be helpful but unfortunately, to our 
knowledge, there is no commercially available balloon 
catheter that is MRI compatible. The balloon catheter causes 
MRI susceptibility artifacts and cannot be used in the 
magnet. The cause of permanent MCAO after withdrawal of 
the balloon catheter was likely due to vasospasm. Future 
baboon stroke studies will increase sample size to establish 
reproducibility, establish ADC and CBF viability thresholds, 
include other multimodal MRI methods (i.e. fMRI and pH 
MRI), investigate different MCAO durations to mimic 
various clinical conditions from hyperacute to chronic phase, 
evaluate functional reorganization in chronic stroke, and 
compare with immunohistology and behavioral/neurological 
scores. Future studies will also explore the embolic stroke 
model, which may better mimic clinical conditions albeit the 
infarct volumes produced will likely be more variable 
compared to the balloon occlusion approach. The NHP 
stroke model is more expensive than the rodent model, so 
rodent stroke models will remain indispensable for initial 
testing of novel imaging modalities and emerging 
therapeutic interventions.  
CONCLUSION 
  Perfusion-diffusion mismatch, which approximates the 
ischemic penumbra, was detected in a clinically relevant, 
large non-human primate (baboon) stroke model. 
Reperfusion salvaged substantial amount of mismatch tissue 
compared to permanent stroke. These initial findings offer 
Fig. (4). Transient MCAO: (a) cerebral blood flow (CBF, upper row) and apparent diffusion coefficient (ADC, lower row) maps of an animal 
subjected to a 60-min transient occlusion. (b) Temporal evolution of lesion volumes were defined by CBF and ADC abnormalities. Final 
infarct volume, as determined by T2-weighted FLAIR MRI, is also shown. The grayscale bar indicates a CBF of 0 to 120 mL/100g/min and 
an ADC of 0 to 0.3 x 10
-3 mm
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encouraging results to further explore the baboon stroke 
model with multimodal MRI. There are a number of 
dissimilarities between rodent and human brains that may 
lead to differences in response to identical ischemic insults. 
The timing, dose and other aspects of pharmacokinetics in 
humans could not be easily extrapolated from rodent models, 
which may have contributed, in part, to the negative 
outcomes of some clinical trials on stroke treatments. Thus, 
this large NHP stroke model has the potential to accelerate 
clinical translations of novel therapeutics and imaging tools 
in stroke research.  
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